Donate For Public and Patients Store Search

C019 - Botulinum Toxin: Video Instruction and Live Panel Discussion

Sunday, March 3; 1:00 PM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Describe the uses for neuromodulators
  • Recognize and manage complications from using neuromodulators


This session will include video presentations by world-class faculty highlighting both on label and off label uses of neuromodulators.


  • Chilukuri, Suneel, MD: Aclaris Therapeutics Inc. – Speaker/Faculty Education(H); Aerolase – Speaker/Faculty Education(H); Alastin Skincare, Inc – Speaker/Faculty Education(H); Allergan, Inc – Speaker/Faculty Education(H); Alma Lasers – I(NC); BTL Industries – Speaker/Faculty Education(H); Cynosure, Inc – Speaker/Faculty Education(H); Eclipse Medical – Speaker/Faculty Education(EQ); Galderma USA – Speaker/Faculty Education(H); InMode MD Ltd – Speaker/Faculty Education(H); PCA SKIN – Speaker/Faculty Education(H); SkinMedica, Inc. – I(Grants/Research Funding); Suneva Medical, Inc. – Speaker/Faculty Education(H); Theravant Corporation – Speaker/Faculty Education(H);
  • Cox, Sue Ellen, MD: Allergan, Inc. – A(H), I(OB); Bayer Pharmaceuticals – I(OB); Candela Corporation – A(H); Candesant Biomedical, Inc. – SH(ST); Cearna, Inc – A(SO); Croma-Pharma GmbH Austria – I(OB); Evolus, Inc. – I(OB); Galderma Laboratories, L.P. – I(H); Merz Aesthetics – SP(H); Neothetics – I(OB); Revance Therapeutics, Inc. – I(OB); TEOXANE Laboratories – I(OB); TruInject Medical Corporation – A(NC); Valeant Pharmaceuticals North America LLC – C(H);
  • Humphrey, Shannon, MD: Allergan, Inc – Speaker/Faculty Education(H); Allergan, Inc. – A(H), I(Grants/Research Funding); Evolus, Inc. – I(H); Galderma Laboratories, L.P. – SP(H); Galderma Laboratories, LP – A(H); L'OrĂ©al France – SP(H); Merz Aesthetics – C(H); Revance Therapeutics, Inc. – C(H), I(Grants/Research Funding), SP(H);
  • Maas, Corey, MD: Allergan, Inc – I(Grants/Research Funding); Galderma USA – I(Grants/Research Funding); Merz Aesthetics – A(H);
  • Matarasso, Seth L., MD: no financial relationships exist with commercial interests.
  • Monheit, Gary D., MD: Allergan, Inc. – C(H), I(Grants/Research Funding); Croma-Pharma GmbH Austria – I(Grants/Research Funding); Evolus, Inc. – I(Grants/Research Funding); Galderma Laboratories, L.P. – C(H), I(Grants/Research Funding); Merz Pharmaceuticals, LLC – C(H); Revance Therapeutics, Inc. – C(H), I(Grants/Research Funding); Sienna Biopharmaceuticals – I(Grants/Research Funding); Suneva Medical, Inc. – C(NC), I(Grants/Research Funding); TEOXANE Laboratories – I(Grants/Research Funding);
  • Weinkle, Susan H., MD: Allergan, Inc – C(H), I(H); Allergan, Inc. – A(H), SP(H); Alphaeon – I(H); Derm Advance – I(NC), SH(NC); Ethicon, Inc. – A(H), C(H), SP(H); Galderma Laboratories, L.P. – C(H), SP(H); Merz Aesthetics – A(H), C(H), SP(H); Procter & Gamble Company – C(H); Sinclair Pharma – C(H), I(H); TEOXANE Laboratories – I(H);
  • Woodward, Julie, MD: Allergan, Inc – C(H); Galderma USA – Speaker/Faculty Education(H); Merz Aesthetics – A(H); Prollenium Medical Technologies – A(H); SkinCeuticals LLC – A(H);
Event Details
  • Date
    Sunday, March 3
  • Time
    1:00 PM - 4:00 PM
  • Location
    Room 146A
  • CME Credits
  • Type
  • Suneel Chilukuri, MD, FAAD
  • Corey Maas, MD
  • Gary D. Monheit, MD, FAAD
  • Julie Woodward, MD
  • Seth L. Matarasso, MD, FAAD
  • Shannon Humphrey, MD, FAAD
  • Sue Ellen Cox, MD, FAAD
  • Susan H. Weinkle, MD, FAAD